Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Total Liabilities : ¥162.6 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Inner Mongolia Grand Pharmaceutical Co Total Liabilities?

Inner Mongolia Grand Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥162.6 Mil.

Inner Mongolia Grand Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2024 (¥182.40 Mil) to Dec. 2024 (¥183.69 Mil) but then declined from Dec. 2024 (¥183.69 Mil) to Mar. 2025 (¥162.55 Mil).

Inner Mongolia Grand Pharmaceutical Co's annual Total Liabilities increased from Dec. 2022 (¥163.56 Mil) to Dec. 2023 (¥251.92 Mil) but then declined from Dec. 2023 (¥251.92 Mil) to Dec. 2024 (¥183.69 Mil).

Inner Mongolia Grand Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Inner Mongolia Grand Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inner Mongolia Grand Pharmaceutical Co Total Liabilities Chart

Inner Mongolia Grand Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

133.76

150.55

163.56

251.92

183.69

Inner Mongolia Grand Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															189.10	189.88	182.40	183.69	162.55

Inner Mongolia Grand Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Inner Mongolia Grand Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	159.707	+	(0.682	+	22.896
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.407)
	=	183.7

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	662.094	-	478.402
	=	183.7

Inner Mongolia Grand Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	139.471	+	(0.603	+	22.073
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.407)
	=	162.6

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	642.245	-	479.691
	=	162.6

Inner Mongolia Grand Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Grand Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Inner Mongolia Grand Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inner Mongolia Grand Pharmaceutical Co Ltd (BJSE:836433) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Wuwei Road, 2nd Floor, Administration Building, Ruyi Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010010

Website

http://www.nmdt.com.cn

Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production and sales of special specialty medicines and general health products. The company's main business is the research and development and production of Chinese patent medicines (including ethnic medicines) and chemical preparations and sales.

Inner Mongolia Grand Pharmaceutical Co Headlines

No Headlines